These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15016335)

  • 1. Complement as a source of biomarkers in systemic lupus erythematosus: past, present, and future.
    Liu CC; Ahearn JM; Manzi S
    Curr Rheumatol Rep; 2004 Apr; 6(2):85-8. PubMed ID: 15016335
    [No Abstract]   [Full Text] [Related]  

  • 2. New advances in measurement of complement activation: lessons of systemic lupus erythematosus.
    Liu CC; Manzi S; Danchenko N; Ahearn JM
    Curr Rheumatol Rep; 2004 Oct; 6(5):375-81. PubMed ID: 15355750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-bound complement activation products as lupus biomarkers: diagnosis, monitoring and stratification.
    Ahearn JM; Liu CC; Manzi S
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1133-1142. PubMed ID: 29025354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis.
    Qi S; Chen Q; Xu D; Xie N; Dai Y
    Lupus; 2018 Sep; 27(10):1582-1590. PubMed ID: 29720035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probable systemic lupus erythematosus with cell-bound complement activation products (CB-CAPS).
    Lamichhane D; Weinstein A
    Lupus; 2016 Aug; 25(9):1050-3. PubMed ID: 26911153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACR classification criteria for systemic lupus erythematosus: complement components.
    Nived O; Sturfelt G
    Lupus; 2004; 13(11):877-9. PubMed ID: 15580986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-bound complement activation products (CB-CAPs) have high sensitivity and specificity in pediatric-onset systemic lupus erythematosus and correlate with disease activity.
    Hui-Yuen JS; Gartshteyn Y; Ma M; O'Malley T; Conklin J; Eichenfield AH; Imundo LF; Dervieux T; Askanase AD
    Lupus; 2018 Dec; 27(14):2262-2268. PubMed ID: 30376789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights Gained From the Study of Pediatric Systemic Lupus Erythematosus.
    Lo MS
    Front Immunol; 2018; 9():1278. PubMed ID: 29922296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced lupus erythematosus.
    Hoff BH
    Chest; 1979 Jan; 75(1):107-8. PubMed ID: 421513
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory investigation of systemic lupus erythematosus.
    Horwitz CA
    Postgrad Med; 1980 Apr; 67(4):193-6, 199-200. PubMed ID: 6154292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies, complement and type I interferon as biomarkers for personalized medicine in SLE.
    Biesen R; Rose T; Hoyer BF; Alexander T; Hiepe F
    Lupus; 2016 Jul; 25(8):823-9. PubMed ID: 27252258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The specificity of passive hemagglutination and complement fixation techniques in diagnosing systemic lupus erythematosus.
    JOKINEN EJ; MAKITALO R
    Acta Rheumatol Scand; 1960; 6():297-302. PubMed ID: 13790406
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement and properdin: biologic and clinical importance.
    Ruddy S
    Orthop Clin North Am; 1975 Jul; 6(3):609-17. PubMed ID: 1099503
    [No Abstract]   [Full Text] [Related]  

  • 14. [Complement in pregnant women with systemic lupus erythematosus].
    Porcel JM
    Med Clin (Barc); 1994 Apr; 102(15):594. PubMed ID: 8189789
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of pleural fluid complement activity in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Glovsky MM; Louie JS; Pitts WH; Alenty A
    Clin Immunol Immunopathol; 1976 Jul; 6(1):31-41. PubMed ID: 949879
    [No Abstract]   [Full Text] [Related]  

  • 16. The significance of serum complement levels for the diagnosis and prognosis of acute and subacute glomerulonephritis and lupus erythematosus disseminatus.
    LANGE K; WASSERMAN E; SLOBODY LB
    Ann Intern Med; 1960 Oct; 53():636-46. PubMed ID: 13758803
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biological diagnosis of systemic lupus erythematosus].
    Hilliquin P; Weill BJ
    Ann Med Interne (Paris); 1991; 142(7):515-20. PubMed ID: 1789530
    [No Abstract]   [Full Text] [Related]  

  • 18. New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus.
    Manzi S; Ahearn JM; Salmon J
    Lupus; 2004; 13(5):298-303. PubMed ID: 15230282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Process of complement activation in systemic lupus erythematosus and acute nephritis].
    Otani I
    Nihon Jinzo Gakkai Shi; 1976 Sep; 18(9):547-63. PubMed ID: 1034132
    [No Abstract]   [Full Text] [Related]  

  • 20. Biomarkers for systemic lupus erythematosus: a review and perspective.
    Liu CC; Manzi S; Ahearn JM
    Curr Opin Rheumatol; 2005 Sep; 17(5):543-9. PubMed ID: 16093831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.